Mounjaro and Colon Cancer: Evidence, Risk and Safety Guidance Written by Bolt Pharmacy Published 30/10/2025 Last Updated 21/5/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Recent discussions have raised questions about Mounjaro and colon cancer risk, prompting concern amongst patients and […]
Tag Archives: Mounjaro health information
Does Mounjaro Cause Fever? UK Clinical Guidance Written by Bolt Pharmacy Published 31/10/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus. Patients and clinicians often ask: does Mounjaro cause fever? Fever is not listed as a common side effect in the […]
Mounjaro: What Supplements to Take During Treatment Written by Bolt Pharmacy Published 14/10/2025 Last Updated 2/6/2026 Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes management, with significant effects on appetite and gastric emptying. Many patients wonder what supplements to take with Mounjaro to support nutritional […]
Loopy Off the Mounjaro: Causes, Safety, and Management Written by Bolt Pharmacy Published 6/11/2025 Last Updated 16/4/2026 Feeling ‘loopy’ on Mounjaro (tirzepatide) is a colloquial term some patients use to describe dizziness, light-headedness, mental fog, or disorientation during treatment. Mounjaro is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 […]
What Colour Is Mounjaro? UK Pen Identification Guide Written by Bolt Pharmacy Published 27/10/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes and weight management. The pre-filled pens use a colour-coded system to help identify different dosage strengths—2.5 mg, 5 mg, 7.5 mg, 10 mg, […]
Does Mounjaro Make You Sad? Mood Effects Explained Written by Bolt Pharmacy Published on 3/7/2026 Does Mounjaro make you sad? This question concerns many patients starting tirzepatide treatment for type 2 diabetes or weight management in the UK. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed by the MHRA, with common side effects primarily […]
Does Mounjaro Cause Numbness? UK Clinical Guidance Written by Bolt Pharmacy Published on 5/5/2026 Does Mounjaro cause numbness? This question concerns many patients prescribed tirzepatide for type 2 diabetes or weight management. Numbness and tingling (paraesthesia) are not listed as recognised adverse reactions in the UK Summary of Product Characteristics for Mounjaro. However, patients may […]
How to Wean Off Mounjaro: Safe Discontinuation Guide Written by Bolt Pharmacy Published on 22/7/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes management. Whilst effective for glycaemic control, various medical, practical, or personal circumstances may necessitate discontinuation. Understanding how to wean off Mounjaro safely […]
Does Mounjaro Cause Blood Clots? Evidence and Safety Profile Written by Bolt Pharmacy Published on 10/6/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for managing type 2 diabetes mellitus. As with any medication, patients may have concerns about potential side effects, including whether Mounjaro causes blood clots. Understanding […]
Does Mounjaro Cause Bleeding? UK Clinical Evidence and Guidance Written by Bolt Pharmacy Published on 15/7/2026 Does Mounjaro cause bleeding? This question concerns many patients prescribed tirzepatide for type 2 diabetes management. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults. Whilst […]
- 1
- 2